Nasal Congestion News and Research

RSS

New smartwatch app helps men to boost sexual performance

Simply180, a full service marketing and advertising agency announced today the beta launch of "Fitdix", a new app it developed that uses smartwatch and artificial intelligence technology to help men end their reliance on pharmaceuticals to boost sexual performance and reduce premature ejaculation.

31 Mar 2017

Study: Depressed patients with chronic rhinosinusitis more likely to miss days of work or school

Depressed patients with chronic rhinosinusitis are more likely to miss days of work or school than those without depression symptoms, according to the results of a new study led by the Sinus Center at Massachusetts Eye and Ear.

10 Mar 2017

FDA approves new nasal spray for adults who overproduce urine at night

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night).

3 Mar 2017

Nasal breathing may help get better night's sleep

The Secret to Sleep could be right under your nose. Many of us are unaware of how we breathe at night - which can lead to a raft of sleep problems. According to The Sleep Ambassador, Nancy H. Rothstein, your nose may help you wake up to a better night's sleep.

16 Jan 2017

Study provides specific information about characteristics of dust mite allergens

Scientists from the National Institutes of Health have determined what differentiates dust mite allergens from the non-allergen proteins dust mites produce.

19 Oct 2016

Anesthetic administered with nasal spray effective in preventing pain during dental treatment

A fear of pain causes many people with dental phobias to avoid or delay needed treatment. In some cases, the injection of a numbing agent can be the most painful part of the visit.

26 Aug 2016

Health care resource use and costs of H.P. Acthar® gel for multiple sclerosis relapse

Mallinckrodt plc, a leading global specialty biopharmaceutical company, today announced new retrospective health economic data on H.P. Acthar® Gel (repository corticotropin injection; RCI), which may be an option for the management of multiple sclerosis (MS) relapses.

6 Jul 2016

Anthim (obiltoxaximab) injection approved for treatment of inhalational anthrax

On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.

21 Mar 2016

WAO to address effects of climate change on pollen allergy season during World Allergy Week 2016

Warmer weather brings joy to most people but misery for hay fever (pollen allergy) sufferers. For 50 million people in the United States alone, spring means sneezing spasms, itchy and watery eyes, and congestion at an annual cost of 18 billion.

21 Mar 2016

Sudler New York wins 2016 Medical Advertising Hall of Fame Heritage Award

Sudler New York has been named a recipient of the 2016 Medical Advertising Hall of Fame Heritage Award. The Heritage Award, established to preserve the history of healthcare advertising by acknowledging those whose contributions have made a positive difference, was given to Sudler for what is referred to as the "Mona Lisa of nasal decongestion"—an iconic campaign called "The Fat Head."

17 Feb 2016

FDA approves Promacta to treat pediatric patients with chronic immune thrombocytopenic purpura

The U.S. Food and Drug Administration today approved Promacta (eltrombopag) to treat low blood platelet count in pediatric patients – ages one year and older – with a rare blood disorder called chronic immune thrombocytopenic purpura (ITP). Promacta can be used in these children when they have not achieved an appropriate response using other ITP medicines or surgery to remove the spleen.

9 Oct 2015

Breakthrough antibody therapy shows significant promise against drug-resistant multiple myeloma

In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute and other organizations report today online in the New England Journal of Medicine.

27 Aug 2015

Daratumumab achieves 29.2% overall response rate in heavily pre-treated patients with multiple myeloma

Data from the international, multi-center, open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) trial show treatment with single-agent daratumumab – an investigational, human anti-CD38 monoclonal antibody – achieved an overall response rate (ORR) of 29.2 percent (95% CI, 20.8-38.9), as assessed by an independent review committee, in heavily pre-treated patients with multiple myeloma.

30 May 2015

Meta-analysis supports ambrisentan efficacy

A meta-analysis supports the efficacy of ambrisentan in patients with pulmonary arterial hypertension.

15 May 2015

Meta-analysis finds that high dose zinc acetate lozenges may help reduce duration of cold symptoms

According to a meta-analysis published in BMC Family Practice, high dose zinc acetate lozenges shortened the duration of common-cold associated nasal discharge by 34%, nasal congestion by 37%, scratchy throat by 33%, and cough by 46%.

16 Mar 2015

Mayo Clinic expert explains difference between severe sepsis and septic shock

Sepsis can be a dangerous complication of almost any type of infection, including influenza, pneumonia and food poisoning; urinary tract infections; bloodstream infections from wounds; and abdominal infections.

14 Jan 2015

Reforestation can reduce ragweed pollen that triggers hay fever

When it comes to controlling hay fever-triggering ragweed plants on Detroit vacant lots, occasional mowing is worse than no mowing at all, and promoting reforestation might be the best solution.

18 Jun 2014

Survey uncovers how summertime congestion and illness can interfere with outdoor fun

For many, the battle with nasal congestion can linger beyond spring allergy season and into the summer months. As the first day of summer approaches, the makers of ARM & HAMMER™ Simply Saline™, the #1 brand of saline-based nasal mists, conducted a nationwide survey to uncover how summertime congestion and illness can interfere with outdoor fun and family vacations.

17 Jun 2014

Knowing summer allergies

As if a runny nose and red eyes weren't enough to ruin your warm weather look, summer allergies can gift you with even more than you've bargained for this year. In fact, some unusual symptoms can leave you looking like you lost a round in a boxing ring.

11 Jun 2014

Northwestern Medicine allergist offers tips to fight allergies

Nasal congestion, sneezing, and itchy and watery eyes — for the nearly 50 million Americans with seasonal allergies, these are the true rites of spring

31 May 2014